Pharmacological Stress Cardiovascular Magnetic Resonance

References

• . Hundley WG, Hamilton CA, Thomas MS,. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography Circulation. 1999;100(16):1697–1702
   PubMed Web of Science ®Google Scholar
• . Hamilton CA, Link KM, Salido TB, Epstein FH, Hundley WG. Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging? J Cardiovasc Magn Reson. 2001;3(4):297–302
   PubMed Web of Science ®Google Scholar
• . Wahl A, Paetsch I, Gollesch A,. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischemia: experience in 1000 consecutive cases. Eur Heart J. 2004;25(14):1230–1236
   PubMedGoogle Scholar
• . Shellock F. Reference Manual for Magnetic Resonance Safety, Implants, and Devices: 2010 Edition. Los Angeles, CA: Biomedical Research Publishing Group and Shellock R&D Services, Inc; 2010
   Google Scholar
• . Kaufman L, Crooks L, Sheldon P, Hricak H, Herfkens R, Bank W. The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis. Circulation. 1983;67(2):251–257
   PubMedGoogle Scholar
• . Van der Wall EE, Vliegen HW, de Roos A, Bruschke AV. Magnetic resonance imaging in coronary artery disease. Circulation. 1995;92(9):2723–2739
   PubMed Web of Science ®Google Scholar
• . Reeder SB, Du YP, Lima JA, Bluemke DA. Advanced cardiac MR imaging of ischemic heart disease. Radiographics. 2001;21(4):1047–1074
   PubMedGoogle Scholar
• . Hundley WG, Hamilton CA, Rerkpattanapipat P. Magnetic resonance imaging assessment of cardiac function. Curr Cardiol Rep. 2003;5(1):69–74
   PubMedGoogle Scholar
• . Kuijpers D, van Dijkman PR, Janssen CH, Vliegenthart R, Zijlstra F, Oudkerk M. Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol. 2004;14(11):2046–2052
   PubMedGoogle Scholar
• . Wahl A, Paetsch I, Gollesch A,. High-dose dobutamine stress cardiac magnetic resonance imaging–has its time come? Eur Heart J. 2004;25(14):1183–1184
   PubMedGoogle Scholar
• . Kuijpers D, Janssen CH, van Dijkman PR, Oudkerk M. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol. 2004;14(10):1823–1828
   PubMedGoogle Scholar
• . Pennell DJ. Cardiovascular magnetic resonance and the role of adenosine pharmacologic stress. Am J Cardiol. 2004;94(2A):26D–31D
   Google Scholar
• . Karamitsos TD, Ntusi NA, Francis JM,. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:66–73
   PubMed Web of Science ®Google Scholar
• . Javadi H, Shariati M, Mogharrabi M,. The Association of Dipyridamole Side Effects with Hemodynamic Parameters, ECG Findings, and Scintigraphy Outcomes. J Nucl Med Technol. 2010;38(3):149–152
   PubMedGoogle Scholar
• . Gould KL, Lipscomb K. Effects on coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34(1):48–55
   PubMed Web of Science ®Google Scholar
• . Sechtem U, Sommerhoff BA, Markiewicz W, White RD, Cheitlin MD, Higgins CB. Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. Am J Cardiol. 1987;59(1):145–151
   PubMedGoogle Scholar
• . White RD, Cassidy MM, Cheitlin MD,. Segmental evaluation of left ventricular wall motion after myocardial infarction: magnetic resonance imaging versus echocardiography. Am Heart J. 1988;115(1 pt 1):166–175
   PubMedGoogle Scholar
• . Buser PT, Auffermann W, Holt WW,. Non-invasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance. J Am Coll Cardiol. 1989;13(6):1294–1300
   PubMedGoogle Scholar
• . Pettigrew RI, Oshinski JN, Chatzimavroudis G, Dixon WT. MRI techniques for cardiovascular imaging. J Magn Reson Imaging. 1999;10(5):590–601
   PubMed Web of Science ®Google Scholar
• . Schalla S, Klein C, Paetsch I,. Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology. 2002;224(3):845–851
   PubMedGoogle Scholar
• . Wilke N, Jerosch-Herold M, Wang Y,. Myocardial perfusion reserve: assessment with multi-section, quantitative, first-pass MR imaging. Radiology. 1997;204(2):373–384
   PubMed Web of Science ®Google Scholar
• . Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology. 1990;174(3 pt 1):757–762
   PubMed Web of Science ®Google Scholar
• . Pennell DJ, Underwood SR, Manzara CC,. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol. 1992;70(1):34–40
   PubMed Web of Science ®Google Scholar
• . Nagel E, Lehmkuhl HB, Bocksch W,. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999;99(6):763–770
   PubMed Web of Science ®Google Scholar
• . Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50(14):1343–1353
   PubMed Web of Science ®Google Scholar
• . Lubbers DD, Janssen CH, Kuijpers D,. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. Int J Cardiovasc Imaging. 2008;24(1):69–76
   PubMedGoogle Scholar
• . Gebker R, Jahnke C, Manka R,. Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ Cardiovasc Imaging. 2008;1(2):122–130
   PubMed Web of Science ®Google Scholar
• . Gebker R, Mirelis JG, Jahnke C,. Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion magnetic resonance during dobutamine stress. Circ Cardiovasc Imaging. 2010;3(5):507–514
   PubMedGoogle Scholar
• . Ishida N, Sakuma H, Motoyasu M,. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology. 2003;229(1):209–216
   PubMedGoogle Scholar
• . Takase B, Nagata M, Kihara T,. Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease. Jpn Heart J. 2004;45(3):475–486
   PubMedGoogle Scholar
• . Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004;44(11):2173–2181
   PubMed Web of Science ®Google Scholar
• . Pilz G, Bernhardt P, Klos M, Ali E, Wild M, Höfling B. Clinical implication of adenosine–stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol. 2006;95(10):531–538
   PubMedGoogle Scholar
• . Klem I, Heitner JF, Shah DJ,. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47(8):1630–1638
   PubMedGoogle Scholar
• . Cury RC, Cattani CA, Gabure LA,. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology. 2006;240(1):39–45
   PubMedGoogle Scholar
• . Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010;12(1):29–38
   PubMedGoogle Scholar
• . Cheng AS, Pegg TJ, Karamitsos TD,. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol. 2007;49(25):2440–2449
   PubMed Web of Science ®Google Scholar
• . Plein S, Schwitter J, Suerder D,. k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology. 2008;249(2):493–500
   PubMedGoogle Scholar
• . Manka R, Vitanis V, Boesiger P,. Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging. 2010;3:710–717
   PubMedGoogle Scholar
• . Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002;106(18):2328–2333
   PubMed Web of Science ®Google Scholar
• . Jahnke C, Nagel E, Gebker R,. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007;115(13):1769–1776
   PubMed Web of Science ®Google Scholar
• . Bodi V, Sanchis J, Lopez-Lereu MP,. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischemic cascade. Heart. 2009;95(1):49–55
   PubMedGoogle Scholar
• . Doesch C, Seeger A, Doering J,. Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging. 2009;2(4):424–433
   PubMedGoogle Scholar
• . Steel K, Broderick R, Gandla V,. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009;120(14):1390–1400
   PubMedGoogle Scholar
• . Lo KY, Leung KF, Chu CM, Loke KL, Chan CK, Yue CS. Prognostic value of adenosine stress myocardial perfusion by cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease [published online ahead of print January 7, 2011]. QJM.
   Google Scholar
• . Walsh TF, Dall'Armellina E, Chughtai H,. Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson. 2009;11:25
   PubMedGoogle Scholar
• . Charoenpanichkit C, Morgan TM, Hamilton CA,. Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing. Circ Cardiovasc Imaging. 2010;3(4):392–397
   PubMedGoogle Scholar
• . Dall'Armellina E, Morgan TM, Mandapaka S,. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol 2008;5(4):279–286
   Google Scholar
• . Korosoglou G, Elhmidi Y, Steen H,. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1493 consecutive patients. Assessment of myocardial wall motion and perfusion. J Am Cardiol Coll. 2010;56(15):1225–1234
   PubMedGoogle Scholar
• . Shaw LJ, Berman DS, Maron DJ,. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–1291
   PubMed Web of Science ®Google Scholar
• . Gebker R, Jahnke C, Hucko T,. Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart. 2010;96(8):616–620
   PubMedGoogle Scholar
• . Wallace EL, Morgan TM, Walsh TF,. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging. 2009;2(3):299–307
   PubMedGoogle Scholar
• . Doyle M, Fuisz A, Kortright E,. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson. 2003;5(3):475–485
   PubMed Web of Science ®Google Scholar
• . Lerakis S, Janik M, McLean DS,. Adenosine stress magnetic resonance imaging in women with low risk chest pain: the Emory University experience. Am J Med Sci. 2010;339(3):216–220
   PubMedGoogle Scholar
• . Klem I, Greulich S, Heitner JF,. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging 2008;1(4):436–445
   PubMedGoogle Scholar
• . Doyle M, Weinberg N, Pohost GM,. Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Imaging. 2010;3(10):1030–1036
   PubMedGoogle Scholar
• . Wahl A, Paetsch I, Roethemeyer S, Klein C, Freck E, Nagel E. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology. 2004;233(1):210–216
   PubMedGoogle Scholar
• . Zoghbi WA, Barasch E. Dobutamine MRI: a serious contender in pharmacological stress imaging? Circulation. 1999;99(6):730–732
   PubMedGoogle Scholar
• . Heilmaier C, Bruder O, Meier F,. Dobutamine stress cardiovascular magnetic resonance imaging in patients after invasive coronary revascularization with stent placement. Acta Radiol. 2009;50(10):1134–1141
   PubMed Web of Science ®Google Scholar
• . Chong WCF, Collins P, Webb CM,. Comparison of flow characteristics and vascular reactivity of radial artery and long saphenous vein grafts. J Cardiothorac Surg. 2006;1:4
   PubMedGoogle Scholar
• . Fenchel M, Franow A, Stauder NI,. Myocardial perfusion after angioplasty in patients suspected of having single-vessel coronary artery disease: Improvement detected at rest stress first-pass perfusion MR imaging–initial experience. Radiology. 2005;237(1):67–74
   PubMedGoogle Scholar
• . Bernhardt P, Spiess J, Levenson B,. Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol. JACC Cardiovasc Imaging. 2009;2(11):1292–1300
   PubMedGoogle Scholar
• . Rerkpattanapipat P, Morgan TM, Neagle CM, Link KM, Hamilton CA, Hundley WG. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol. 2002;90(4):416–419
   PubMed Web of Science ®Google Scholar
• . Lerakis S, McLean DS, Anadiotis AV,. Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. J Cardiovasc Magn Reson. 2009;11:37–43
   PubMed Web of Science ®Google Scholar
• . Miller CD, Hwang W, Hoekstra JW,. Stress cardiac magnetic resonance imaging with observation unit care reduces cost for patients with emergent chest pain: a randomized trial. Ann Emerg Med. 2010;56(3):209–219
   PubMedGoogle Scholar
• . Vogel-Claussen J, Skrok J, Dombroski D,. Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: comparison with nuclear stress test. J Magn Reson Imaging. 2009;30(4):753–762
   PubMedGoogle Scholar
• . Greenwood JP, Younger JF, Ridgway JP,. Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart. 2007;93(11):1363–1368
   PubMed Web of Science ®Google Scholar
• . Cheng AS, van Gaal WJ, Francis JM,. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Int J Cardiovasc Imaging. 2009;25:277–283
   PubMedGoogle Scholar
• . Darty SN, O'Neal J, Wesley-Farrington D, Davis AD, Link KM, Hundley G. Cardiovascular magnetic resonance imaging. Prog Cardiovasc Nurs. 2004;19(2):60–67
   PubMedGoogle Scholar
• . Mandapaka S, Hundley WG. Dobutamine cardiovascular magnetic resonance: a review. J Magn Reson Imaging. 2006;24(3):499–512
   PubMedGoogle Scholar
• . Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:59
   PubMed Web of Science ®Google Scholar
• . Karamitsos TD, Arnold JR, Pegg TJ,. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease. Int J Cardiovasc Imaging. 2009;25(3):277–283
   PubMedGoogle Scholar
• . Hundley WG, Bluemke DA, Finn JP,. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on expert consensus documents. Circulation. 2010;121(22):2462–2508
   PubMed Web of Science ®Google Scholar
• . Hundley WG, Bluemke D, Bogaert JG,. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2009;11:5
   PubMedGoogle Scholar
• . Prasad SR, Jagirdar J. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists. J Comput Assist Tomogr. 2008;32(1):1–3
   PubMedGoogle Scholar
• . Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA. Nephrogenic systemic fibrosis: Incidence, associations, and effect of risk factor assessment: report of 33 cases. Radiology. 2009;250(2):371–377
   PubMed Web of Science ®Google Scholar
• . Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol. 2008;180(3):830–835
   PubMedGoogle Scholar
• . Altun E, Martin DR, Wertman R,. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy–report from two U.S. universities. Radiology. 2009;253(3):689–696
   PubMed Web of Science ®Google Scholar
• . Jekic M, Foster EL, Ballinger MR, Raman SV, Simonetti OP. Cardiac function and myocardial perfusion immediately following maximal treadmill exercise inside the MRI room. J Cardiovasc Magn Reson. 2008;10:3
   PubMed Web of Science ®Google Scholar
• . Rerkpattanapipat P, Gandhi SK, Darty SN,. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol. 2003;92:603–606
   PubMed Web of Science ®Google Scholar
• . Raman SV, Dickerson JA, Jekic M,. Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT. J Cardiovasc Magn Reson. 2010;12:41
   PubMedGoogle Scholar
• . Karamitsos TD, Leccisotti L, Arnold JR,. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging. 2010;3(1):32–40
   PubMed Web of Science ®Google Scholar
• . Jahnke C, Gebker R, Manka R,. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. J Am Coll Cardiol Img. 2010;3(4):375–384
   Google Scholar
• . Manka R, Paetsch I, Schnackenburg B, Gebker R, Fleck E, Jahnke C. BOLD cardiovascular magnetic resonance at 3.0 tesla in myocardial ischemia. J Cardiovasc Magn Reson. 2010;12:54
   PubMedGoogle Scholar